USPTO serial 79191754
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,950
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph W. Secondine, Jr.
Joseph W. Secondine, Jr. New England Biolabs, Inc.240 County RoadIpswich, MA 01938UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in manufacture; biological preparations for use in synthetic biology and molecular biology, other than for medical use; biological substances, for use in synthetic biology and molecular biology, other than for medical or veterinary use; reagents for use in scientific apparatus for chemical or biological analysis; biochemical reagents for use in biological processing other than for medical or veterinary purposes; biochemical catalysts; catalysts for chemical and biochemical processes; biochemical substances other than for medical use, namely, biochemicals, namely, polypeptides for in vitro research use; reagents for scientific purposes; reagents used in science; reagents for medical research; reagents for research purposes; laboratory reagents for scientific use; testing reagents for scientific use; [ research reagents for industrial use, namely, for food testing; ] chemical reagents for scientific purposes; [ diagnostic reagents for scientific use; test reagents other than for medical use, namely, paternity identity tests comprised of reagents; ] reagents for scientific or medical research use; diagnostic reagents for scientific or research use; [ diagnostic reagents and preparations, except for medical or veterinary use; reagents for scientific microbiological analysis other than for medical or veterinary purposes; ] reagents for scientific laboratory purposes other than for medical or veterinary purposes; [ diagnostic reagents, other than for medical or veterinary use for sale in kit form; ] chemical reagents for use in science, other than for medical or veterinary use; [ chemical reagents for use in diagnostic tests, other than for medical or veterinary use; diagnostic preparations for scientific purposes; diagnostic preparations used in science; diagnostic preparations for scientific use; diagnostic substances, namely, diagnostic preparations other than for medical or veterinary use; chemical diagnostic reagents for scientific industrial use, other than for medical or veterinary use; diagnostic preparations for scientific or research use; diagnostic reagents, other than for medical or veterinary laboratory use; diagnostic reagents, except for medical or veterinary use; diagnostic chemical preparations other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations other than for medical or veterinary purposes; clinical diagnostic reagents, other than for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, other than for medical or veterinary use; diagnostic preparations for scientific or research use other than for medical use; ] biological and biochemical reagents for scientific use; [ diagnostic reagents for scientific use; ] biological preparations for use in cell cultures other than for medical or veterinary use, for sale in kit form; a set of reagents for use in cloning and synthetic biology, not for medical or veterinary use; reagents for use in cloning and for use in synthetic biology, not for medical or veterinary use; reagents for use in cloning and for use in synthetic biology for sale in kit form, not for medical or veterinary use; molecular biology reagents for use in cloning and for use in synthetic biology, not for medical or veterinary use; kits for biological substance and/or biological reagents, namely, reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; reagents kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in cloning and for use in synthetic biology, not for medical or veterinary use; molecular biology reagents for the manufacture of biological molecules for scientific molecular biology purposes; [ molecular biology reagents for diagnostic use, not for medical or veterinary use; ] biological reagents, namely, enzymes, not for medical or veterinary use | ACTIVE | — |
| 009 | Computer software for computing results for diagnostic design in the field of molecular biology; computer programmes for computing results for diagnostic design in the field of molecular biology; software for computing results for diagnostic design in the field of molecular biology; [ computers and computer hardware; ] computer application software for computing results for diagnostic design in the field of molecular biology, namely, for computing results for diagnostic design in the field of molecular biology; [ computer firmware for computing results for diagnostic design in the field of molecular biology; recorded computer programs for computing results for diagnostic design in the field of molecular biology; ] computer programs in the nature of downloadable software for computing results for diagnostic design in the field of molecular biology; downloadable computer software applications for computing results for diagnostic design in the field of molecular biology; [ computer software for authorising access to data bases; ] downloadable software for computing results for diagnostic design in the field of molecular biology; interface software for computing results for diagnostic design in the field of molecular biology [ ; firmware for computer peripherals for computing results for diagnostic design in the field of molecular biology ] | ACTIVE | — |
| 042 | [ Advisory services relating to scientific research; advisory services relating to molecular biology research; advisory services relating to scientific research; advisory services relating to technological research; biological analysis; biological cloning services; ] biological product development services; biological scientific laboratory services; biological research; biological research services; [ consultancy relating to biotechnology; consultancy relating to laboratory testing; consultancy relating to computer software; providing information on the subject of scientific research in the field of biochemistry and biotechnology; ] laboratory analysis in the field of biochemistry and biotechnology; laboratory research in the field of biochemistry and biotechnology; scientific laboratory services for molecular biology; [ information technology consulting services in relation to molecular biology; laboratory services, namely, preparation of biological samples for research purposes; laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; laboratory services, namely, preparation of biological samples for analysis in research laboratories; preparation of scientific reports for others; providing information relating to scientific research in the fields of biochemistry and biotechnology; provision of information relating to scientific research; ] scientific research; scientific research relating to biology; scientific research relating to chemistry; providing on-line non-downloadable software tools for computing results for diagnostic experimental design in the field of molecular biology for use in molecular biology or diagnostic experimental design | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 12, 2024 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 27, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 27, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Feb 12, 2024 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jan 3, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 4, 2023 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 11, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 19, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 19, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 5, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 18, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 31, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 21, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 28, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 28, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 27, 2017 | ALIE | ASSIGNED TO LIE | — |
| Feb 27, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 28, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 28, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 27, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |